CEO of Novo Nordisk, maker of weight loss drug Wegovy, to step down in wake of share price drop

Danish pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss drug Wegovy, said Friday its CEO was stepping down by "mutual agreement" with the company's board of directors, citing "recent market challenges" and a steep decline in the company's share price.